Huons Biopharma registers Phase 3 trial of HU-045 in glabellar lines
The study was first posted on ClinicalTrials.gov on October 13, 2026. It plans to enroll 390 participants and compares HU-045 to Xeomin in adults with moderate or severe glabellar lines.
Primary source
ClinicalTrials.gov registry record, October 13, 2026
To Evaluate HU-045 With Moderate to Severe Glabellar Lines
Read the source: To Evaluate HU-045 With Moderate to Severe Glabellar Lines clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation